ARCHIVES

In Brief: James Downing named CEO of St. Jude

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Breslow Reported Choice As HEW Asst. secretary

January 28, 1977

Cancer Education Applications Suspended Pending Restructuring

March 21, 1986

Also in this 8-page issue: NIH Conflict of Interest panel recommends that NIH employees should not receive stock options or equities as compensation for outside work.

May 7, 2004

Regulations Threaten Clinical Trials Higgins contends

May 16, 1980

UC Davis Is U.S. Site For Trial Of Exemestane For Breast Ca.

September 24, 2004

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

September 27, 1985